30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement
Firas Zahr(Cleveland Clinic Lerner College of Medicine), Martin B. Leon(Columbia University Irving Medical Center), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Susheel Kodali(Columbia University Irving Medical Center), Hemal Gada(University of Pittsburgh Medical Center), Jeremy J. Thaden(Mayo Clinic in Arizona), Eric S. Weiss(University of Pittsburgh), Isaac George(Columbia University), John Heiser(Corewell Health), Howard K. Song(Oregon Health & Science University), Tanvir Bajwa(Aurora Health Care), Angie Zhang(The University of Texas at Austin), Michael J. Reardon(Houston Methodist), Scott Chadderdon(Oregon Health & Science University), David Adams(Mount Sinai Health System), William Merhi(Corewell Health), Merick Kirshner, Timothy Byrne, Mubashir Mumtaz(University of Pittsburgh Medical Center), D. Scott Lim(University of Virginia Health System)
Cited by 79
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k